HIF-2α distribution in ccRCC, head & neck, and colorectal cancer are 15%, 5%, and 11% respectively, meaning relatively few tumor cells express HIF-2α in positive cases. The gene discussed is EPAS1; the disease is nonpapillary renal cell carcinoma.